Article

SABCS: Debu Tripathy Discusses Hormonal Therapy Advances in Breast Cancer

Debu Tripathy reports on recent studies involving hormone therapy in estrogen receptor-positive breast cancer.

Debu Tripathy, editor-in-chief of CURE magazine, reports on recent studies involving hormone therapy in estrogen receptor-positive breast cancer. Two trials called SOFT and TEXT were combined and long-term follow-up results were announced at the San Antonio Breast Cancer Symposium. In the combined results, certain groups of patients, but not all, did seem to receive a benefit with tamoxifen in addition to shutting down the ovaries.

"This is an important conversation for patients to have when they are completing their therapy if their tumor is hormone-sensitive, and they're going to be getting hormone therapy and they're pre-menopausal (they're still having their periods)," he says. "For some patients, this may help."

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of Doctor.
Building long-term trust with providers can help patients with MPNs feel supported, encourage them to speak up and navigate care with confidence.
The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy.
Image of Dr. Doug
Image of doctor.
Image of Dr. Kelly
Image of Dr. Boffa.
Immune Therapy Expands Melanoma Treatment to More Patients
Bladder preservation for bladder cancer requires balancing clinical factors and patient health with a personalized treatment plan.
image of doctor D'Sa
Related Content